|
|
Noordhollandstraat 71
Amsterdam, 1081 AS Netherlands
phone:(31) 20 301 8500
fax:(31) 20 642 0173
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.nddo.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Studies of anticancer agents. |
|
| Management |
| Coenraad K. van Kalken, M.D., Ph.D., Chief Executive Officer; Eric van der Putten, Chief Operating Officer; John van Driel, Chief Financial Officer |
| |
|
|
| |
|
| Keywords |
| anticancer, agents, pharmaceutical, biotech, agents, oncology, driug, angiogenesis, inhibitors, vaccines, gene, chemotherapy, biostatistics |
|
|
|
| Description |
|
NDDO Oncology designs and conducts clinical and preclinical studies of anticancer agents in collaboration with pharmaceutical and biotech companies. |
|
| Products / Services |
NDDO Oncology holds a large and diverse new anticancer drug portfolio and is a major specialized organization in the field of anticancer drug development.
|
|
| Technology / Differentiation |
| NDDO has experience with the new leads in Oncology (angiogenesis inhibitors, vaccines, gene therapy, novel chemotherapy, MoAbs, signal transduction inhibitors etc.). |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members